[Greg H]

Hey Y'all!

I got word Tuesday that I have been accepted into the National Institutes of Health's Campath trial for younger (I feel less bald and less grey every time I get to use that adjective!), low-risk MDSers.

I am pretty stoked about this, because I am convinced (after much careful study) that the kind of MDS I have should respond to immunosuppression. And I like the idea that Campath is more of a rifle shot at a couple types of T-cells instead of a shotgun applied to the whole immune system.

We'll be looking for transfusion independence and normal cytogenetics.

Now I just have to figure out how to fit the two weeks at NIH into running a small business. Looking at the calendar, I may finish up with the Campath on Christmas Eve. Yikes!

Greg